At the conclusion of the Hematology and Oncology Best Practices course, the successful learner will be able to:

Hematology

• Understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors
• Understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies
• Understand blood and marrow morphology and hematopathology
• Understand red cell disorders

Hematologic Malignancies

• Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs
• Be familiar with the diagnosis, evaluation, and management of hematologic malignancies
• Identify strategies for taking the board examinations

Oncology

• Understand the epidemiology of malignant diseases and management of the medical complications of malignancy
• Comprehend the principles of management of gynecologic and other genito-urinary malignancies
• Identify the latest advances in cancers of the lung, the breast, and the gastrointestinal tract
• Recognize principles of new developments in biologic therapy of cancer
• Contend with complexity of HIV-related malignancies

COURSE OVERVIEW

Hematology Sessions:

• Day 1: Hemoglobinopathies, White Cell Disorders, Bone Marrow Failure and Sickle Cell Disease Overview
• Day 2: Clotting and Bleeding Disorders
• Day 3: TTP, HUS, DIC, HIT, ABO Incompatibility, Hematopoietic Transplantation and Hematologic Complications of Pregnancy

Hematologic Malignancies Sessions:

• Day 4: Lymphomas, CLL, ALL, CML, Plasma Cell Disorders, and MDS
• Day 5: AML, Bone Marrow Transplantation, Myeloproliferative Neoplasms and Pharmacology

Medical Oncology Sessions:

• Day 6: Breast Cancer, Lung Cancer, and Neuro-Oncology
• Day 7: Renal Cell, Prostate, Bladder, Testicular, Ovarian and Endometrial Tumors
• Day 8: GI Oncology, Mesothelioma and Sarcomas